Uname: Linux dedi-15171674.espacofacial.com.br 5.14.0-687.36.1.el9_8.x86_64 #1 SMP PREEMPT_DYNAMIC Fri Aug 7 05:40:49 EDT 2026 x86_64
Software: Apache
PHP version: 8.2.33 [ PHP INFO ] PHP os: Linux
Server Ip: 104.21.5.151
Your Ip: 216.73.217.58
User: espa7358 (1004) | Group: espa7358 (1003)
Safe Mode: OFF
Disable Function:
NONE

name : dovecot.index.cache
��PjmD^j
�.�����3Date: Tue, 3 Jun 2025 19:31:22 +0000 (UTC)
J"Subject: =?UTF-8?B?Q29uaGXDp2EgbyBub3ZvIExpcHMgUGx1cyBMaWRvIA==?=
:From: Rennova <[email protected]>
>Reply-To: Rennova <[email protected]>
	0 To:   <[email protected]>


�!Message-ID: <cam-rennova_bulk_712.mail_cmbgwzla0hewd0846s6pu2j39.campogrande=espacofacial.com.br-po@espacofacial.com.br>
f$Content-Type: multipart/alternative; 
	boundary="----=_Part_23344268_919796061.1748979082874"
�M?hL.&Date: Tue, 03 Jun 2025 12:46:29 -0600
g$Subject: =?UTF-8?Q?Manuten=C3=A7=C3=A3o_de_rede_da_sua_Oi_Fibra_conclu?=
 =?UTF-8?Q?=C3=ADda?=
;"From: "Relacionamento Oi" <[email protected]>
	.#To: <[email protected]>


R,Message-ID: <[email protected]>
J-Content-Type: multipart/alternative;
	boundary="Abchuz0vNdvn=_?:"
C?h�3Date: Tue, 3 Jun 2025 15:42:02 +0000 (UTC)
!Subject: Quem avisa...
:From: Rennova <[email protected]>
>Reply-To: Rennova <[email protected]>
	0To:   <[email protected]>


� Message-ID: <cam-rennova_bulk_711.mail_cmbgoso20wvje0884977jbrs4.campogrande=espacofacial.com.br-po@espacofacial.com.br>
d#Content-Type: multipart/alternative; 
	boundary="----=_Part_5413505_31282237.1748965322954"
�?h�3Date: Tue, 3 Jun 2025 21:31:10 +0000 (UTC)
%"Subject: Descubra o Segredo!
:From: Rennova <[email protected]>
>Reply-To: Rennova <[email protected]>
	0 To:   <[email protected]>


�!Message-ID: <cam-rennova_bulk_714.mail_cmbh19n8rkc3407635x0fqd6w.campogrande=espacofacial.com.br-po@espacofacial.com.br>
g$Content-Type: multipart/alternative; 
	boundary="----=_Part_18258131_1524473829.1748986270446"
�i?h�3Date: Wed, 4 Jun 2025 11:04:42 +0000 (UTC)
"Subject: Falta 1 Dia! 
:From: Rennova <[email protected]>
>Reply-To: Rennova <[email protected]>
	0 To:   <[email protected]>


�!Message-ID: <cam-rennova_bulk_715.mail_cmbhubv1i6oax0825jfoatdcc.campogrande=espacofacial.com.br-po@espacofacial.com.br>
f$Content-Type: multipart/alternative; 
	boundary="----=_Part_6175524_1080511952.1749035082728"
J(@h�3Date: Wed, 4 Jun 2025 13:33:08 +0000 (UTC)
R!Subject: =?UTF-8?B?Q29uaGXDp2EgYWdvcmEgZXNzZSBzdXBlciBsYW7Dp2FtZW50byE=?=
:From: Rennova <[email protected]>
>Reply-To: Rennova <[email protected]>
	0To:   <[email protected]>


� Message-ID: <cam-rennova_bulk_713.mail_cmbhzmr3vn6ww07723lwh9lx4.campogrande=espacofacial.com.br-po@espacofacial.com.br>
f#Content-Type: multipart/alternative; 
	boundary="----=_Part_6411457_1118032995.1749043988926"
K@h�3Date: Wed, 4 Jun 2025 21:28:02 +0000 (UTC)
F"Subject: =?UTF-8?B?TcOhcmNpYSBTZW5zaXRpdmEgcHJldml1ISDwn5GA?=
:From: Rennova <[email protected]>
>Reply-To: Rennova <[email protected]>
	0 To:   <[email protected]>


�!Message-ID: <cam-rennova_bulk_719.mail_cmbiglfnh3lnp0772f14gj7pj.campogrande=espacofacial.com.br-po@espacofacial.com.br>
e$Content-Type: multipart/alternative; 
	boundary="----=_Part_7240948_793081208.1749072482421"
b�@h�3Date: Wed, 4 Jun 2025 23:07:02 +0000 (UTC)
$"Subject: Vai ficar de fora?
:From: Rennova <[email protected]>
>Reply-To: Rennova <[email protected]>
	0 To:   <[email protected]>


�!Message-ID: <cam-rennova_bulk_716.mail_cmbik4r5vdvvm0711v2rlos4j.campogrande=espacofacial.com.br-po@espacofacial.com.br>
g$Content-Type: multipart/alternative; 
	boundary="----=_Part_25106899_1835637218.1749078422646"
��@h�.&Date: Thu, 05 Jun 2025 07:03:58 -0600
J%Subject: =?UTF-8?Q?Viva_a_Experi=C3=AAncia_Rennova_por_completo?=
;#From: "Rennova" <[email protected]>
�*Reply-To: "INNOVAPHARMA BRASIL FARMACEUTICA LTDA" <reply-fefa1075746300-1307_HTML-22533317-546009621-94@mkt.innovapharma.com>
	.$To: <[email protected]>


S-Message-ID: <[email protected]>
J.Content-Type: multipart/alternative;
	boundary="4s02sduVJ5Ml=_?:"
��Ah�.&Date: Thu, 05 Jun 2025 07:04:15 -0600
J%Subject: =?UTF-8?Q?Viva_a_Experi=C3=AAncia_Rennova_por_completo?=
;#From: "Rennova" <[email protected]>
�*Reply-To: "INNOVAPHARMA BRASIL FARMACEUTICA LTDA" <reply-fefa1075746300-1307_HTML-77528735-546009621-96@mkt.innovapharma.com>
	.$To: <[email protected]>


S-Message-ID: <[email protected]>
J.Content-Type: multipart/alternative;
	boundary="4s02sduVJ5Ml=_?:"
ϕAh�3Date: Thu, 5 Jun 2025 13:08:12 +0000 (UTC)
F"Subject: =?UTF-8?B?TcOhcmNpYSBTZW5zaXRpdmEgcHJldml1ISDwn5GA?=
:From: Rennova <[email protected]>
>Reply-To: Rennova <[email protected]>
	0 To:   <[email protected]>


�!Message-ID: <cam-rennova_bulk_718.mail_cmbje6irhzytu0825q9xbs3wd.campogrande=espacofacial.com.br-po@espacofacial.com.br>
e$Content-Type: multipart/alternative; 
	boundary="----=_Part_7727598_115274525.1749128892038"
��Ah�3Date: Thu, 5 Jun 2025 15:27:35 +0000 (UTC)
R"Subject: =?UTF-8?B?UmVjYWRvIGRhIE3DoXJjaWEgU2Vuc2l0aXZhIHBhcmEgdm9jw6oh?=
:From: Rennova <[email protected]>
>Reply-To: Rennova <[email protected]>
	0 To:   <[email protected]>


�!Message-ID: <cam-rennova_bulk_720.mail_cmbjj5scbacq60741lskeki74.campogrande=espacofacial.com.br-po@espacofacial.com.br>
e$Content-Type: multipart/alternative; 
	boundary="----=_Part_7948343_371759931.1749137255877"
g�Ah�3Date: Mon, 2 Jun 2025 21:41:49 +0000 (UTC)
F"Subject: =?UTF-8?B?TXVpdG8gbWFpcyBFbGxldmEgcGFyYSB2b2PDqiE=?=
:From: Rennova <[email protected]>
>Reply-To: Rennova <[email protected]>
	0 To:   <[email protected]>


�!Message-ID: <cam-rennova_bulk_710.mail_cmbfm7hn6lyue0741nsa2w3y2.campogrande=espacofacial.com.br-po@espacofacial.com.br>
f$Content-Type: multipart/alternative; 
	boundary="----=_Part_4820026_1266250222.1748900509461"
�>h	/Return-Path: <[email protected]>
 <A�%L&���A&pssH�&\_��H*[^�)
U@�7CK��@FCKT�@�UEMdy�z�(("text" "plain" ("charset" "iso-8859-1") NIL NIL "quoted-printable" 708 16 NIL NIL NIL NIL)("text" "html" ("charset" "iso-8859-1") NIL NIL "quoted-printable" 3369 85 NIL NIL NIL NIL) "alternative" ("boundary" "_000_CP8P284MB24316B3F05FAF44EE4C87D56F46FACP8P284MB2431BRAP_") NIL NIL NIL)("image" "png" ("name" "image001.png") "<[email protected]>" "image001.png" "base64" 3322 NIL ("inline" ("filename" "image001.png" "size" "2425" "creation-date" "Thu, 05 Jun 2025 18:55:59 GMT" "modification-date" "Thu, 05 Jun 2025 18:55:59 GMT")) NIL NIL)("image" "png" ("name" "image002.png") "<[email protected]>" "image002.png" "base64" 3716 NIL ("inline" ("filename" "image002.png" "size" "2715" "creation-date" "Thu, 05 Jun 2025 18:55:59 GMT" "modification-date" "Thu, 05 Jun 2025 18:55:59 GMT")) NIL NIL)("image" "jpeg" ("name" "image003.jpg") "<[email protected]>" "image003.jpg" "base64" 31480 NIL ("inline" ("filename" "image003.jpg" "size" "23003" "creation-date" "Thu, 05 Jun 2025 18:55:59 GMT" "modification-date" "Thu, 05 Jun 2025 18:55:59 GMT")) NIL NIL) "related" ("boundary" "_006_CP8P284MB24316B3F05FAF44EE4C87D56F46FACP8P284MB2431BRAP_" "type" "multipart/alternative") NIL ("pt-BR") NIL-%Date: Thu, 5 Jun 2025 18:55:59 +0000
;"Subject: Comunicado Importante - 4Bio Medicamentos
3 From: Preventiva <[email protected]>
	P!To: "[email protected]" <[email protected]>


e&Message-ID:
 <CP8P284MB24316B3F05FAF44EE4C87D56F46FA@CP8P284MB2431.BRAP284.PROD.OUTLOOK.COM>
�qContent-Type: multipart/related;
	boundary="_006_CP8P284MB24316B3F05FAF44EE4C87D56F46FACP8P284MB2431BRAP_";
	type="multipart/alternative"
?�Ah�nj��tjnjnj��tj��tj��tjnj��tj��tj��tjnjnj��tjnjlD^j��tjlD^jnj��tj��tj��tjnjnjnjnjnj��tj��tj������������������������������������������������������������������������������������������������������������flagsdate.receivedimap.bodystructuremime.partshdr.datehdr.subjecthdr.fromhdr.senderhdr.reply-tohdr.tohdr.cchdr.bcchdr.in-reply-tohdr.message-idhdr.referenceshdr.importancehdr.x-priorityhdr.x-open-xchange-share-urlhdr.CONTENT-TRANSFER-ENCODINGhdr.CONTENT-TYPEhdr.DISPOSITION-NOTIFICATION-TOhdr.LIST-POSThdr.MAIL-FOLLOWUP-TOhdr.MAIL-REPLY-TOhdr.RESENT-BCChdr.RETURN-PATHhdr.X-DRAFT-INFOhdr.X-KOLAB-MIME-VERSIONhdr.X-KOLAB-TYPE�<]Return-Path: <b-rennova-mail_cmbfm7hn6lyue0741nsa2w3y2-a69f75-p@in.innovapharma.com>
 �A�
�1�2HUX��
H	TW;/�/�("text" "plain" ("charset" "utf-8") NIL NIL "quoted-printable" 397 13 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") NIL NIL "quoted-printable" 12252 161 NIL NIL NIL NIL) "alternative" ("boundary" "----=_Part_4820026_1266250222.1748900509461") NIL NIL NIL48]Return-Path: <b-rennova-mail_cmbjj5scbacq60741lskeki74-402900-p@in.innovapharma.com>
 �A�*`'�'H!UX��HFTW�%
&�("text" "plain" ("charset" "utf-8") NIL NIL "quoted-printable" 169 7 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") NIL NIL "quoted-printable" 9738 129 NIL NIL NIL NIL) "alternative" ("boundary" "----=_Part_7948343_371759931.1749137255877") NIL NIL NILx8]Return-Path: <b-rennova-mail_cmbje6irhzytu0825q9xbs3wd-cddbf6-p@in.innovapharma.com>
 �A�['�'HUX��H:TW�%&�("text" "plain" ("charset" "utf-8") NIL NIL "quoted-printable" 169 7 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") NIL NIL "quoted-printable" 9733 129 NIL NIL NIL NIL) "alternative" ("boundary" "----=_Part_7727598_115274525.1749128892038") NIL NIL NILp<]Return-Path: <b-rennova-mail_cmbik4r5vdvvm0711v2rlos4j-7ed654-p@in.innovapharma.com>
 �A��'�'H�UX��HTW4%�%("text" "plain" ("charset" "utf-8") NIL NIL "quoted-printable" 169 7 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") NIL NIL "quoted-printable" 9651 127 NIL NIL NIL NIL) "alternative" ("boundary" "----=_Part_25106899_1835637218.1749078422646") NIL NIL NILX
<]Return-Path: <b-rennova-mail_cmbhubv1i6oax0825jfoatdcc-d103bf-p@in.innovapharma.com>
 �A���&'H�UX��HTW%�%("text" "plain" ("charset" "utf-8") NIL NIL "quoted-printable" 169 7 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") NIL NIL "quoted-printable" 9618 127 NIL NIL NIL NIL) "alternative" ("boundary" "----=_Part_6175524_1080511952.1749035082728") NIL NIL NIL�<]Return-Path: <b-rennova-mail_cmbh19n8rkc3407635x0fqd6w-272faf-p@in.innovapharma.com>
 �A��'�'H�UX��H
TW8%�%("text" "plain" ("charset" "utf-8") NIL NIL "quoted-printable" 169 7 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") NIL NIL "quoted-printable" 9655 127 NIL NIL NIL NIL) "alternative" ("boundary" "----=_Part_18258131_1524473829.1748986270446") NIL NIL NIL,<]Return-Path: <b-rennova-mail_cmbgoso20wvje0884977jbrs4-6f3594-p@in.innovapharma.com>
 �A���1�2H�UX��
H�TW$/�/�("text" "plain" ("charset" "utf-8") NIL NIL "quoted-printable" 397 13 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") NIL NIL "quoted-printable" 12228 160 NIL NIL NIL NIL) "alternative" ("boundary" "----=_Part_5413505_31282237.1748965322954") NIL NIL NIL�dReturn-Path: <bounce-60_HTML-207749232-396378-534003561-938@bounce.info.niointernet.com.br>
 �A�|KMH
LP
]
NHyKOj@�A4�("text" "plain" ("charset" "utf-8") NIL NIL "8bit" 2653 78 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") NIL NIL "8bit" 16798 308 NIL NIL NIL NIL) "alternative" ("boundary" "Abchuz0vNdvn=_?:") NIL NIL NIL <]Return-Path: <b-rennova-mail_cmbgwzla0hewd0846s6pu2j39-21ae55-p@in.innovapharma.com>
 �A�3�2�3H+UX*H�TW�/&0�("text" "plain" ("charset" "utf-8") NIL NIL "quoted-printable" 554 17 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") NIL NIL "quoted-printable" 12326 162 NIL NIL NIL NIL) "alternative" ("boundary" "----=_Part_23344268_919796061.1748979082874") NIL NIL NIL�<]Return-Path: <b-rennova-mail_cmbhzmr3vn6ww07723lwh9lx4-4dac10-p@in.innovapharma.com>
 �A�23�3H+UX*H�TW�/U0�("text" "plain" ("charset" "utf-8") NIL NIL "quoted-printable" 554 17 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") NIL NIL "quoted-printable" 12373 163 NIL NIL NIL NIL) "alternative" ("boundary" "----=_Part_6411457_1118032995.1749043988926") NIL NIL NIL�8]Return-Path: <b-rennova-mail_cmbiglfnh3lnp0772f14gj7pj-9ef120-p@in.innovapharma.com>
 �A�?'�'HUX��H:TWh%�%�("text" "plain" ("charset" "utf-8") NIL NIL "quoted-printable" 169 7 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") NIL NIL "quoted-printable" 9705 129 NIL NIL NIL NIL) "alternative" ("boundary" "----=_Part_7240948_793081208.1749072482421") NIL NIL NIL�`Return-Path: <bounce-1307_HTML-77528735-45174-546009621-96@bounce.mkt.innovapharma.com>
 �Az� .�.H�LP#	H	%H>KO�#i$o�("text" "plain" ("charset" "utf-8") NIL NIL "8bit" 2376 37 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") NIL NIL "8bit" 9321 111 NIL NIL NIL NIL) "alternative" ("boundary" "4s02sduVJ5Ml=_?:") NIL NIL NIL`Return-Path: <bounce-1307_HTML-22533317-45174-546009621-94@bounce.mkt.innovapharma.com>
 �Ax� .�.H�LP#	H	%H<KO�#i$o�("text" "plain" ("charset" "utf-8") NIL NIL "8bit" 2376 37 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") NIL NIL "8bit" 9321 111 NIL NIL NIL NIL) "alternative" ("boundary" "4s02sduVJ5Ml=_?:") NIL NIL NIL
© 2026 UnknownSec